ICDM 2026

Committee sessions

Key issues and challenges in telemedicine for diabetes (K) Key issues and challenges in telemedicine for diabetes: shaping the KDA practice guidance Chair(s): Seak Ki Yun, Jae-Seung Yun Thursday 15 October, 14:30-15:30 Room 2

The amendment to the Medical Service Act establishing a legal framework for telemedicine was promulgated in December 2025 and is scheduled to take effect in December 2026. The successful integration of telemedicine into routine diabetes care requires careful consideration of regulatory requirements, clinical effectiveness, patient safety, and practical implementation challenges. This session will provide a comprehensive overview of the current landscape of telemedicine-based diabetes care, addressing both policy and clinical perspectives. Experts in the field will discuss key challenges associated with implementing telemedicine safely and effectively, and share real-world experiences from diabetes care practice. The session will also explore future directions for the development of telemedicine guidelines that can support high-quality, equitable, and sustainable diabetes management.

CS1-L1 Yong Jin KwonSeoul National University, Korea: Telemedicine regulation in Korea: principles and directions

CS1-L2 Jin Suk KimKMA Research Institute for Healthcare Policy, Korea: Safety concerns in telemedicine and the role of KDA practice standards

CS1-L3 Hun-Sung KimThe Catholic University of Korea, Korea: Structuring telemedicine guidance for diabetes: an endocrinologist's perspective

Panel discussion

CS1-P1
Jeunghun HanFriend Dr.Han Clinic, Korea
CS1-P2
Jaewon SunMerakiplace Inc. (My Doctor), Korea
CS1-P3
Jong-Ha BaekGyeongsang National University, Korea
CS1-P4
Myung Jin KimHallym University, Korea

Registration of pancreatic disability (K) Challenges for the health and welfare following the recognition of pancreatic disability Chair(s): Soo Mi Jang, Suk Chon Thursday 15 October, 14:30-15:30 Room 3

This session has been organized to share the institutional background and clinical criteria following the introduction of the pancreatic disability registration system, and to discuss the social challenges that will arise following the registration of individuals with these conditions. It will serve as an opportunity to reflect on the significance of this registration and to explore ways for multidisciplinary teams to collaborate in establishing a support system for the future.

CS2-L1 Jaehyun KimSeoul National University, Korea: Establishing pancreatic endocrine dysfunction as an internal organ disability: background and criteria

CS2-L2 Kyung Mee KimSoongsil University, Korea: Quality of life and social challenges following registration as a person with a disability

Panel discussion

CS2-P1
Yu Jeong ParkAnsan University, Korea
CS2-P2
Junyoung KimHallym University Dongtan Sacred Heart Hospital, Korea

KDA clinical practice guidelines committee session (K) Highlights from the 2027 KDA clinical practice guidelines, 10th edition Chair(s): Seung-Hyun Ko, Young Min Cho Friday 16 October, 13:40~15:00 Room 2

This session previews the 2027 KDA Clinical Practice Guidelines (10th edition). Presentations highlight major revisions and the Korean evidence-generation initiative behind them, evolving type 2 diabetes treatment strategies emphasizing weight and cardiovascular-kidney-metabolic risk, the adoption of next-generation incretin therapies, and expanded indications for continuous glucose monitoring and digital health. Together, the talks show how emerging research and local data are shaping the future of diabetes care in Korea.

CS3-L1 Jae Hyun BaeSeoul National University, Korea: Overview of key revisions and the Korean evidence initiative

CS3-L2 Jin Hwa KimChosun University, Korea: Updating the T2D algorithm: weight-centric and CKM-oriented approaches

CS3-L3 Tae Jung OhSeoul National University, Korea: Next-generation incretin therapies for people with obesity and T2D: from global trials to Korean practice

CS3-L4 Sun-Joon MoonSungkyunkwan University, Korea: Expanding CGM indications and digital health integration

Diabetes & Metabolism Journal session The best paper of the year 2026 Chair(s): Kyung Mook Choi, Junghyun Noh Friday 16 October, 13:40~15:00 Room 7

The Diabetes and Metabolism Journal (DMJ) is the official journal of the Korean Diabetes Association, with an impact factor of 8.2 in 2025. This session presents research from six outstanding papers published in 2025, carefully selected by the Publication Committee through a rigorous review process. We appreciate your continued support for DMJ's growth and development.

CS4-L1 Rosa OhChungbuk National University, Korea: Metabolic dysfunction-associated steatotic liver disease and all-cause and cause-specific mortality

CS4-L2 Mijin KimPusan National University, Korea: Use of glucagon-like peptide-1 receptor agonists does not increase the risk of cancer in patients with type 2 diabetes mellitus

CS4-L3 Ji Yoon KimKyung Hee University, Korea: Prevalence, incidence, and metabolic characteristics of young adults with type 2 diabetes mellitus in South Korea (2010–2020)

CS4-L4 Chae Beom ParkUniversity of Ulsan, Korea: Macrophage-specific progranulin deficiency prevents diet-induced obesity through the inhibition of hypothalamic and adipose tissue inflammation

CS4-L5 Yujin KimKorea University, Korea: Ultra-processed food intake and risk of type 2 diabetes mellitus: a dose-response meta-analysis of prospective studies

CS4-L6 Wenqi FanThe Second Xiangya Hospital of Central South University, China: Efficacy and safety of automated insulin delivery systems in patients with type 1 diabetes mellitus: a systematic review and meta-analysis

ADS–KDA joint session Bridging technology and clinical action: CGM implementation in the Asia-pacific Chair(s): Chul-Hee Kim, Sof Andrikopoulos Friday 16 October, 16:00~17:20 Room 3

Continuous glucose monitoring (CGM) has emerged as a transformative technology in diabetes management, offering real-time glycemic insights that extend well beyond traditional glucose metrics. This session examines the current landscape of CGM adoption across the Asia-Pacific region, addressing national coverage patterns, policy integration, and standardization challenges. Speakers will further explore the practical clinical implementation of CGM-linked lifestyle self-monitoring devices and the emerging role of artificial intelligence in leveraging CGM-derived data to predict and prevent diabetes complications. By bridging technological innovation with actionable clinical strategies, this session aims to accelerate the equitable and evidence-based integration of CGM into routine diabetes care throughout Asia-Pacific.

CS5-L1 Jae Hyeon KimSungkyunkwan University, Korea: CGM coverage and real-world uptake patterns in Korea: a national registry analysis

CS5-L2 Sof AndrikopoulosAustralian Diabetes Society, Australia: Regulatory standardisation to improve the safety of continuous glucose monitoring systems in Australia and New Zealand: joint ADS/ADEA/ADIPS/ANZSPED/NZSSD statement

CS5-L3 Da Young LeeKorea University, Korea: Clinical implementation of CGM-linked lifestyle self-monitoring devices

CS5-L4 Gaurav PuriAustralian Diabetes Society, Australia: AI transforming diabetes complications

Panel discussion

CS5-P1
Seung-Hyun YooCatholic Kwandong University, Korea
CS5-P2
Ji A SeoKorea University, Korea

Diabetes policy forum (K) Digital transformation and reimbursement policies in diabetes care (당뇨병 관리의 디지털 전환과 보험 정책) Chair(s): Jeunghun Han, Chong Hwa Kim Friday 16 October, 16:00~17:20 Room 7

This session focuses on digital transformation in diabetes care, addressing reimbursement policies for advanced technologies, the integration of management into hospital evaluations, and strategic revisions for medication reimbursement. By exploring policy, clinical, and system-level perspectives, the session highlights practical pathways to improve access, quality, and sustainability in technology-enabled diabetes care.

CS6-L1 Junhwan KimKakao Healthcare, Korea: Global perspectives on reimbursement for advanced diabetes technology: global coverage trends for insulin delivery devices and CGM and a comparative analysis of Korea's coverage-expansion roadmap

CS6-L2 Dughyun ChoiSoonchunhyang University, Korea: Integrating diabetes technology into tertiary hospital evaluation: strategies for enhancing type 2 diabetes management quality

CS6-L3 Ahreum KhangPusan National University, Korea: Strategic revision of the general principles for antidiabetic medication reimbursement based on clinical practice guidelines

Panel discussion

CS6-P1
Jinhan LeeDonga Ilbo, Korea
CS6-P2
SangJoon ParkSoonchunhyang University, Korea
CS6-P3
Ji Hyun LeeAjou University Hospital, Korea
CS6-P4
Sun Young KimSamsung Medical Center, Korea

Nutrition in GLP-1RA therapy (K) Nutrition therapy for patients on GLP-1 receptor agonists: losing fat without losing muscle Chair(s): Jaehyuk Lee, Junghwa Lee Saturday 17 October, 09:00~10:20 Room 6

GLP-1 receptor agonists achieve unprecedented weight loss, but part of the lost weight may come from lean mass. This session examines whether this loss is truly muscle and how to prevent it, from current evidence and emerging therapies to practical guidance on protein and calorie intake and managing weight-loss plateaus, illustrated with real patient cases.

CS7-L1 Jaehyun BaeHallym University, Korea: Is it really muscle loss - and can we prevent it? from evidence to the emerging pipeline

CS7-L2 Yeonhee LeeAjou University Hospital, Korea: The science of eating to keep muscle: protein, energy, and the plateau

CS7-L3 Kyung Hee OhKangbuk Samsung Hospital, Korea: Real patient cases: nutrition counseling during GLP-1RA therapy

Panel discussion

CS7-P1
Han Na JungHallym University, Korea
CS7-P2
Ahreum ShinSeoul National University Bundang Hospital, Korea
CS7-P3
Jae Won ChoSamsung Medical Center, Korea

Young diabetologist boot camp (K) Essential diabetology Chair(s): Jong Chul Won, Nam Hoon Kim Saturday 17 October, 13:30~14:50 Room 6

This boot camp introduces medical students and residents to the core foundations of modern diabetes care, integrating insulin physiology and therapy, CGM-driven clinical decision-making, and landmark trials that reshaped treatment paradigms. By linking basic principles with evidence-based practice, the session will prepare future diabetologists to understand diabetes comprehensively and apply advances confidently in real-world care.

CS8-L1 Jun Sung MoonYeungnam University, Korea: The one ring of diabetology, everything about insulin

CS8-L2 Jae Hyeon KimSungkyunkwan University, Korea: How CGM has transformed diabetes care

CS8-L3 Sin Gon KimKorea University, Korea: Landmark trials that changed diabetes care: from glycemic control to cardiovascular-kidney-metabolic protection

구분		사전등록 Early bird (~2026년 8월 10일까지)		사전등록 Advance (~2026년 9월 11일까지)		현장등록 (2026년 10월 15일 ~ 17일)
구분		KDA회원	비회원	KDA회원	비회원	KDA회원	비회원
Full Day 등록 (10월 15일~17일)	전문의 (개원의, 교수, 봉직의, 전임의 포함)	KRW 240,000	KRW 300,000	KRW 280,000	KRW 350,000	KRW 370,000	KRW 450,000
Full Day 등록 (10월 15일~17일)	전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사, 관련분야 교수 및 기타 (군의관 및 공중보건의 포함)	KRW 140,000	KRW 200,000	KRW 180,000	KRW 230,000	KRW 250,000	KRW 270,000
One-day 등록	전문의 (개원의, 교수, 봉직의, 전임의 포함)	KRW 150,000	KRW 180,000	KRW 170,000	KRW 210,000	KRW 220,000	KRW 270,000
One-day 등록	전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사, 관련분야 교수 및 기타 (군의관 및 공중보건의 포함)	KRW 100,000	KRW 120,000	KRW 120,000	KRW 140,000	KRW 140,000	KRW 160,000
저녁 식사	전체	KRW 55,000
For Korean 전공의 / 의과대학생 / 대학원생(기초, 간호, 영양, 기타 관련 분야) 할인 적용		KRW 50,000 당뇨병학에 관심있는 젊은 연구자 및 전공의를 위한 할인 등록을 제공하고 있습니다. 대한당뇨병학회 회원 추천서 필수 제출 ←클릭 시, 다운로드 할인 등록은 Full-registration으로만 등록이 가능합니다.

Program details

평점안내 (For Korean)